Page 58 - Characterization of genetic neurodevelopmental disorders at adult age, with a focus on 22q11.2 deletion syndrome - Emma Boersma

Chapter 2
117. Hoytema van Konijnenburg EMM, Wortmann SB, Koelewijn MJ, et al. Treatable inherited
metabolic disorders causing intellectual disability: 2021 review and digital app. Orphanet J
Rare Dis. Apr 12 2021;16(1):170. doi:10.1186/s13023-021-01727-2
118. Ebrahimi-Fakhari D, Van Karnebeek C, Münchau A. Movement Disorders in Treatable Inborn
Errors of Metabolism. Mov Disord. May 2019;34(5):598-613. doi:10.1002/mds.27568
119. Overwater IE, Rietman AB, van Eeghen AM, de Wit MCY. Everolimus for the treatment of
refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives.
Ther Clin Risk Manag. 2019;15:951-955. doi:10.2147/tcrm.S145630
120. Tufekcioglu Z, Cakar A, Bilgic B, Hanagasi H, Gurvit H, Emre M. Adult-onset phenylketonuria
with rapidly progressive dementia and parkinsonism. Neurocase. Jun 2016;22(3):273-5. doi:10
.1080/13554794.2016.1142567
121. Magrinelli F, Balint B, Bhatia KP. Challenges in Clinicogenetic Correlations: One Gene - Many
Phenotypes. Mov Disord Clin Pract. Apr 2021;8(3):299-310. doi:10.1002/mdc3.13165
122. Manti F, Nardecchia F, Barresi S, et al. Neurotransmitter trafficking defect in a patient with
clathrin (CLTC) variation presenting with intellectual disability and early-onset parkinsonism.
Parkinsonism Relat Disord. Apr 2019;61:207-210. doi:10.1016/j.parkreldis.2018.10.012
56